Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

Clinical trial NCT03737643 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03737643
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Ovarian Cancer

Start date: 2019-01-04
Primary completion: 2025-03-17
Enrollment: 1407

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.